Literature DB >> 33618708

Symptoms of anxiety disorders in Iranian adolescents with hearing loss during the COVID-19 pandemic.

Saeed Ariapooran1, Mehdi Khezeli2.   

Abstract

BACKGROUND: Anxiety symptoms have been reported in many populations during the COVID-19 pandemic, but not in adolescents with a hearing loss. This study aimed to investigate the presence of symptoms of anxiety disorders (ADs) in adolescents with hearing loss (HL) during the COVID-19 pandemic, 2020.
METHODS: In this cross sectional study, 56 adolescents with HL (aged 12 to 18 years) including 23 deaf, and 33 hard of hearing (HH) were selected from four counties located in western Iran using a census method. Adolescents with HL filled out the self-report of the Screen for Child Anxiety Related Emotional Disorders (SCARED).
RESULTS: The results showed that the presence of symptoms of ADs in adolescents with HL was 37.5%, and higher in deaf than in HH adolescents (60.9% in deaf vs. 21.2% in HH, p = 0.003). Among the subscales, only the Social Anxiety Disorder (39.1% in deaf vs. 90.1 in HH, p = 0.009) and the School Avoidance (52.2% in deaf vs. 24.2% in HH, p = 0.031) significantly differed. The mean score of Panic Disorder, Social Anxiety Disorder, and Anxiety Disorders in the deaf adolescents were higher than in HH ones.
CONCLUSIONS: Our study showed the presence of significant symptoms of ADs in a sample of Iranian adolescents with HL, especially in deaf adolescents, during the COVID-19 pandemic.

Entities:  

Keywords:  Adolescents; Anxiety; COVID-19 pandemic; Deaf; Hearing loss; SCARED

Mesh:

Year:  2021        PMID: 33618708      PMCID: PMC7898254          DOI: 10.1186/s12888-021-03118-0

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


  2 in total

1.  Epidemiology of Psychiatric Disorders in Children and Adolescents in Chaharmahal and Bakhtiari Province, Iran, 2017.

Authors:  Parvin Safavi; Mohammad Reza Mohammadi; Ali Khaleghi; Seyed Ali Mostafavi; Soghra Taheri; Kourosh Shahbazi; Kamal Solati
Journal:  Arch Iran Med       Date:  2019-05-01       Impact factor: 1.354

Review 2.  Prevalence of Anxiety Disorders among Children and Adolescents in Iran: A Systematic Review.

Authors:  Hadi Zarafshan; Mohammad-Reza Mohammadi; Maryam Salmanian
Journal:  Iran J Psychiatry       Date:  2015
  2 in total
  6 in total

1.  Correction to: Symptoms of anxiety disorders in Iranian adolescents with hearing loss during the COVID-19 pandemic.

Authors:  Saeed Ariapooran; Mehdi Khezeli
Journal:  BMC Psychiatry       Date:  2021-04-09       Impact factor: 3.630

2.  SARS-CoV-2 related Paediatric Acute-onset Neuropsychiatric Syndrome.

Authors:  Piero Pavone; Manuela Ceccarelli; Silvia Marino; Daniela Caruso; Raffaele Falsaperla; Massimiliano Berretta; Emmanuele Venanzi Rullo; Giuseppe Nunnari
Journal:  Lancet Child Adolesc Health       Date:  2021-05-04

Review 3.  Children and Adolescents with Disabilities and Exposure to Disasters, Terrorism, and the COVID-19 Pandemic: a Scoping Review.

Authors:  Mana Mann; Julia E McMillan; Ellen J Silver; Ruth E K Stein
Journal:  Curr Psychiatry Rep       Date:  2021-10-13       Impact factor: 5.285

4.  Audio-Vestibular Profile of COVID-19; Systematic Review and Meta-analysis.

Authors:  Mehri Maleki; Mohammad Maarefvand; Ahmad Reza Nazeri; Ali Reza Akbarzadeh Baghban; Azadeh Borna
Journal:  Iran J Otorhinolaryngol       Date:  2022-07

5.  The role of risk perception, risk communication, and demographic factors in COVID-19 preventive behaviors: an online survey in Iran.

Authors:  Mansour Rezaei; Nader Rajabi Gilan; Ali Almasi; Mehdi Khezeli; Fatemeh Jamshidi Nazar; Zahra Jorjoran Shushtari; Yahya Salimi; Farid Najafi; Neda Sarabi; Shahram Saeidi; Saeid Saeidi
Journal:  Osong Public Health Res Perspect       Date:  2022-08-31

6.  Depression, anxiety, and suicidal ideation in nurses with and without symptoms of secondary traumatic stress during the COVID-19 outbreak.

Authors:  Saeed Ariapooran; Batool Ahadi; Mehdi Khezeli
Journal:  Arch Psychiatr Nurs       Date:  2021-05-25       Impact factor: 2.218

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.